Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Selaginella doederleinii extract shows potential for cervical cancer treatment but needs more research.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Topical Ruxolitinib may safely treat severe hair loss.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

Oral etretinate improved hair length and reduced beading in monilethrix.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Abrocitinib may effectively treat Lichen Planopilaris.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

ALRN-6924 may prevent hair loss caused by chemotherapy.